Similarly, a large number of evidence has demonstrated that a variety of human ovarian cancer cell lines have an abundant expression of ezrin and moesin, and that overexpression of ezrin and moesin is highly associated with reduced overall survival and the progression of metastasis in clinical ovarian carcinoma specimens [38,39,40,41,42,43,44]. The gene discussed is EZR; the disease is ovarian carcinoma.